Enhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against Leishmania amazonensis
Molecules · 2024
DOI: 10.3390/molecules29225469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Fabiana Maia Santos Urbancg Moncorvo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz-FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Oximes. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Tecnología e Innovación, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, COLCIENCIAS.
Abstract (Originalsprache)
Leishmaniasis, a protozoan disease affecting humans, exposes significant shortcomings in current treatments. In continuation to our previous findings on amidoxime-based antileishmanial compounds bearing a 4,5-dihydrofuran scaffold, twelve new amidoxime derivatives substituted at position 3 with an amide bearing a nitrogen heterocycle were synthesized. This series was designed to replace the sulfone and aryl group on a previously reported HIT. The synthesis of these compounds involved the following three-step pathway: manganese (III) acetate-based cyclization of a β-ketoester, followed by amidation with LiHMDS and a final reaction with hydroxylamine. Three of them, containing either bromine, chlorine, or methyl substitutions and featuring a pyridine moiety, showed an interesting toxicity–activity relationship in vitro. They exhibited IC50 values of 15.0 µM, 16.0 µM, and 17.0 µM against the promastigote form of the parasite and IC50 values of 0.5 µM, 0.6 µM, and 0.3 µM against the intracellular amastigote form, respectively. A selectivity index (SI) greater than 300 was established between the cytotoxic concentrations (in murine macrophages) and the effective concentrations (against the intracellular form of Leishmania amazonensis). This SI is at least seventy times higher than that observed for Pentamidine and twenty-five times higher than that observed for the reference HIT, as previously reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz-FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro 21040-900, Brazil.
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
- Service Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille (AP-HM), 147 Bd. Baille, 13006 Marseille, France.
ORCID-Profile: Oscar Leonardo Avendaño Leon, Christophe Curti, Sébastien Redon, Eduardo Caio Torres-Santos, Patrice Vanelle
Förderung
- Ministerio de Ciencia, Tecnología e Innovación
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- COLCIENCIAS
- FAPERJ
Zitieren
APA
Maia Santos Urbancg Moncorvo, F., Avendaño Leon, O. L., Curti, C., Kabri, Y., Redon, S., Torres-Santos, E. C., & Vanelle, P. (2024). Enhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against Leishmania amazonensis. Molecules. https://doi.org/10.3390/molecules29225469
Vancouver
Maia Santos Urbancg Moncorvo F, Avendaño Leon OL, Curti C, Kabri Y, Redon S, Torres-Santos EC, et al. Enhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against Leishmania amazonensis. Molecules. 2024. doi:10.3390/molecules29225469
BibTeX
@article{MaiaSantosUrbancgMoncorvo2024,
author = {Maia Santos Urbancg Moncorvo, Fabiana and Avendaño Leon, Oscar Leonardo and Curti, Christophe and Kabri, Youssef and Redon, Sébastien and Torres-Santos, Eduardo Caio and Vanelle, Patrice},
title = {Enhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against Leishmania amazonensis},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225469}
}
EUVIMED